Aurantio-obtusin

CAS : 67979-25-3

Ref. TM-T6S1559

Informations sur le produit

• Nom: Aurantio-obtusin
• Synonymes: 1,3,7-Trihydroxy-2,8-dimethoxy-6-methyl-9,10-anthracenedione, 1,3,7-Trihydroxy-2,8-dimethoxy-6-methylanthracene-9,10-dione, 9,10-Anthracenedione, 1,3,7-trihydroxy-2,8-dimethoxy-6-methyl-, Aurantioobtusin
• CAS: 67979-25-3

Description

1. Biotransformation of glucoAurantio-obtusin towards Aurantio-obtusin increased the toxicity of irinotecan through increased inhibition of SN-38 glucuronidation. 2. Aurantio-obtusin, stimulated chemotactic migration of MC3T3-E1 osteoblast cells in a concentration-dependent manner. Besides migration, the compound stimulated osteoblast differentiation and mineralization. 3. Aurantio-obtusin is a promising osteoanabolic compound of natural origin with potential therapeutic applications in the prevention of osteoporosis and other metabolic bone diseases.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 330.29
• Formule: C₁₇H₁₄O₇
• Degré de pureté: 98.05%
• Couleur/Forme: Solid